These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32135162)

  • 1. A new cell line for assessing HIV-1 antibody dependent cellular cytotoxicity against a broad range of variants.
    Thomas AS; Ghulam-Smith M; Olson A; Coote C; Gonzales O; Sagar M
    J Immunol Methods; 2020 May; 480():112766. PubMed ID: 32135162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.
    Mielke D; Stanfield-Oakley S; Borate B; Fisher LH; Faircloth K; Tuyishime M; Greene K; Gao H; Williamson C; Morris L; Ochsenbauer C; Tomaras G; Haynes BF; Montefiori D; Pollara J; deCamp AC; Ferrari G
    J Virol; 2022 Jan; 96(2):e0164321. PubMed ID: 34730393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.
    von Bredow B; Arias JF; Heyer LN; Moldt B; Le K; Robinson JE; Zolla-Pazner S; Burton DR; Evans DT
    J Virol; 2016 Jul; 90(13):6127-6139. PubMed ID: 27122574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
    J Virol; 2019 May; 93(10):. PubMed ID: 30842324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid degranulation of NK cells following activation by HIV-specific antibodies.
    Chung AW; Rollman E; Center RJ; Kent SJ; Stratov I
    J Immunol; 2009 Jan; 182(2):1202-10. PubMed ID: 19124764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
    Gooneratne SL; Center RJ; Kent SJ; Parsons MS
    Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.
    Veillette M; Désormeaux A; Medjahed H; Gharsallah NE; Coutu M; Baalwa J; Guan Y; Lewis G; Ferrari G; Hahn BH; Haynes BF; Robinson JE; Kaufmann DE; Bonsignori M; Sodroski J; Finzi A
    J Virol; 2014 Mar; 88(5):2633-44. PubMed ID: 24352444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
    Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
    Front Immunol; 2018; 9():3163. PubMed ID: 30697215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.
    Orlandi C; Flinko R; Lewis GK
    J Immunol Methods; 2016 Jun; 433():51-8. PubMed ID: 26969387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.
    von Bredow B; Arias JF; Heyer LN; Gardner MR; Farzan M; Rakasz EG; Evans DT
    J Virol; 2015 Oct; 89(20):10648-55. PubMed ID: 26269175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
    Sangjan S; Ampol S; Tabprasit S; Horthongkham N; Chuenchitra T; Ekpo P; Kantakamalakul W
    Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.
    Davis-Gardner ME; Gardner MR; Alfant B; Farzan M
    PLoS Pathog; 2017 Dec; 13(12):e1006786. PubMed ID: 29253851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
    Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
    J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antibody-dependent cellular cytotoxicity induced by the plasma from persons living with HIV-1 based on target cells with or without CD4 molecules.
    Ding Y; Kong D; Li D; Zhang Y; Hong K; Liang H; Ma L
    Microbes Infect; 2021; 23(4-5):104805. PubMed ID: 33711449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design.
    Madhavi V; Wren LH; Center RJ; Gonelli C; Winnall WR; Parsons MS; Kramski M; Kent SJ; Stratov I
    AIDS; 2014 Aug; 28(13):1859-70. PubMed ID: 24937308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and Denmark.
    Borggren M; Jensen SS; Heyndrickx L; Palm AA; Gerstoft J; Kronborg G; Hønge BL; Jespersen S; da Silva ZJ; Karlsson I; Fomsgaard A
    AIDS Res Hum Retroviruses; 2016 May; 32(5):434-42. PubMed ID: 26621287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1.
    Spenlehauer C; Gordon CA; Trkola A; Moore JP
    Virology; 2001 Feb; 280(2):292-300. PubMed ID: 11162843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.